2022 · JOURNAL OF CLINICAL ONCOLOGY

Radiographic progression in the absence of prostate-specific antigen (PSA) progression in patients with metastatic hormone-sensitive prostate cancer (mHSPC): Post hoc analysis of ARCHES.

Armstrong, Andrew J., Mottet, Nicolas, Iguchi, Taro, Szmulewitz, Russell Zelig, Holzbeierlein, Jeffrey, Villers, Arnauld, Alcaraz, Antonio, Alekseev, Boris, Shore, Neal D., Gomez-Veiga, Francisco, Rosbrook, Brad, Zohren, Fabian, Lee, Ho-Jin, Haas, Gabriel P., Stenzl, Arnulf, Azad, Arun